Morgan Stanley’s Healthcare Triangle HCTI Stock Holding History

Morgan Stanley’s Portfolio HCTI Stock Details HCTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-20,470	Closed	-$55.1K	–	8494
2026 Q1	$55.1K	Buy	20,470 +20,469	+2,046,900%	+$249K	﹤0.01%	6388
2025 Q4	$25	Hold	1	–	–	﹤0.01%	8045
2025 Q3	$105	Hold	1	–	–	﹤0.01%	7674
2025 Q2	$278	Hold	1	–	–	﹤0.01%	7529
2025 Q1	$3K	Hold	1	–	–	﹤0.01%	7097
2024 Q4	$9.86K	Buy	+1	New	+$12.6K	﹤0.01%	6806
2022 Q3	–	Hold	0	–	-$2K	–	7769
2022 Q2	–	Hold	0	–	–	–	7586

Other funds holding HCTI

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Morgan Stanley's HCTI Position: Q2 2026 in Review

Morgan Stanley sold out of Healthcare Triangle (HCTI) in Q2 2026, closing a stake of 20,470 shares — an estimated $55.1K sold.

Morgan Stanley first reported a position in HCTI in Q4 2024 and held it in 6 quarters. The position peaked at $55.1K in Q1 2026. 7 funds tracked by Wall St. Rank hold HCTI as of Q2 2026.

Morgan Stanley reported no remaining Healthcare Triangle position as of Q2 2026 after selling out during the quarter.
Morgan Stanley sold 20,470 Healthcare Triangle shares in Q2 2026, an estimated $55.1K.
Morgan Stanley first reported a position in Healthcare Triangle in Q4 2024 and held it in 6 quarters.
Morgan Stanley's Healthcare Triangle position peaked at $55.1K in Q1 2026.
7 funds tracked by Wall St. Rank held Healthcare Triangle as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.